Medical Buyer’s Post

🌟 Featured Insight from Dr. Felipe Couñago MD PhD - National Clinical Director, GenesisCare Spain 🌟 We are pleased to spotlight a recent contribution by Dr. Felipe Couñago MD PhD, a renowned expert in radiation oncology, addressing a pivotal question in the treatment of Stage III Non-Small Cell Lung Cancer. Key Insight: 🔹 Should patients undergo surgery, or is radiotherapy equally effective? The latest data from the ESPATUE trial suggests that surgery and radiotherapy yield comparable outcomes in terms of quality of life (QOL) and overall survival (OS). Dr. Couñago emphasizes the need for further comparative studies to evaluate the best therapeutic strategies, incorporating advances in systemic therapies such as chemo-immune and targeted treatments. This discussion is critical for shaping future approaches to treatment planning in this patient population. For the full analysis: https://lnkd.in/e4uav6KT #LungCancer #Oncology #RadiationOncology #CancerResearch #ClinicalInsights #MedicalAdvances

Despite efforts to improve national lung cancer screening rates, only 4 % of eligible high-risk patients pursue this opportunity annually. Radiology Partners Research Institute's new open access article uncovers key barriers to lung cancer screening. Highlights of the study include: • Low dose chest CT's increase lung cancer detection rates • High-risk patients rarely receive CT chest screening • Absence of symptoms and lack of awareness are common barriers to screening • A multifaceted approach is needed to improve screening rates Access the full study and explore these insights in-depth: https://bit.ly/3Bkggrs Sameer Rehman MD, MBA, Eric Rohren, Phil Ramis #lungcancer #lungcancerscreening #lowdoseCT #cancerscreening #radiology #medicalimaging #radiologist

❓Have you read the most recent Global Liver Institute Liver Cancer News article? Highlights include: ➡️ Immunotherapy Prior to Surgery May Improve Outcomes for High-Risk Liver Cancer Patients ➡️ Clinical Practice Guidelines for Hepatocellular Carcinoma Surveillance for People at High Risk in Australia ➡️ Novel DNA-Targeting Therapeutic Screening Technique Read the full article👇 https://ow.ly/1wMI50TquiI #MedEd #HCC #LiverCancer

Hello LinkedIn community Brain cancer is a serious condition characterized by the uncontrolled growth of cells within the brain. It can originate in the brain (primary brain cancer) or spread from other parts of the body (secondary, or metastatic, brain cancer). Primary brain tumors can be benign (non-cancerous) or malignant (cancerous), with gliomas and meningiomas being among the most common types. Symptoms of brain cancer vary depending on the tumor's size, location, and rate of growth and may include headaches, seizures, cognitive or personality changes, and motor skill impairments. Diagnosis typically involves imaging studies such as MRI or CT scans, and treatment options include surgery, radiation therapy, and chemotherapy. Advances in medical research are continuously improving the understanding and management of brain cancer, offering hope for better outcomes for patients. #snsinstitutions #snsdesignthinker #designthinking

🔬 Innovative Prostate Cancer Treatment: HIFU 🔬 At GFCT, we’re excited about the latest research into High-Intensity Focused Ultrasound (HIFU), a non-invasive therapy showing promise in treating prostate cancer. 🌟 What is HIFU? HIFU targets and destroys cancer cells using focused ultrasound waves without harming healthy tissue, making it a safer alternative to surgery or radiation. 📈 Is it effective? Recent studies highlight the effectiveness of HIFU in reducing cancer recurrence, with fewer side effects like incontinence or erectile dysfunction. It has potential to improve the lives of prostate cancer patients significantly. ✉️ Support & Funding If you believe you could assist in fundraising to expand these facilities to the Midlands and the North, matching the advanced services available in the South, please contact Graham Fulford at grahamfulford47@gmail.com or call 07831 156071. Find out more about HIFU and latest research papers here: https://lnkd.in/eF-9Re7e #ProstateCancer #HIFU #CancerResearch #MedicalBreakthroughs

#IDEA4RC aims to develop a federated #Data ecosystem for #RareCancers focusing on two groups of these cancers: soft tissue sarcoma and head and neck cancers. We have identified some research questions the data ecosystem would try to answer through interviews with sarcoma and head and neck cancer expert oncologists and a survey conducted among the IDEA4RC clinical partners. Among these questions the consortium will chose at least four pilot projects that will allow to test the platform. The research questions belong to four areas: ▶ description of the natural history of soft tissues sarcomas and head and neck cancers (how the rare cancer develops, progresses, possible association with other diseases, etc.). ▶ evaluation of prognostic factors and response to treatments. ▶ assessment of treatment effectiveness (systemic, radiotherapy, surgery, target therapy, immunotherapy, and possible combinations). ▶ quality of care (diagnostic and staging procedures, treatment strategies, follow-up, etc.). To discover more about the research questions we have selected, read the summary of the deliverable on our website 👉 https://lnkd.in/dssWWegH #EHDS #EuropeanHealthDataSpace

💡 NEW FINDINGS: CCR researchers uncovered a key transcription factor that may influence proteins in small cell lung cancer (SCLC). Small cell lung cancer is a type of fast-growing cancer that forms in the tissues of the lung, and smoking is the major risk factor for the development of this disease. National Cancer Institute (NCI), The National Institutes of Health These new findings highlight the importance of DNA analysis in understanding and treating the disease. Dr. David S. Schrump, chief of our Thoracic Surgery Branch, largely led this research, which was published on April 5, 2024, in the Journal of Thoracic Oncology. #CancerResearch #LungCancer #Health #Innovation #NewResearch

📍 Live from the Canadian Surgery Forum in Winnipeg! We’re here at #CSF2024, sharing how Progress CONNECT can support surgeons in having thoughtful discussions with their breast cancer patients. Research shows that there are over 50 types of breast cancer. Progress CONNECT, designed by Breast Cancer Canada, is an online tool that provides patients with information specific to their type. By answering a series of questions using their pathology results, patients receive a personalized report outlining their breast cancer type and potential treatment options based on stage and biomarker status. The goal? To help patients have meaningful, informed discussions with their oncologists, supported by evidence-based information relevant to their stage and biomarkers. Please visit: progressconnect.ca **Reports are for informational purposes only and are not intended to replace medical advice. Breast Cancer Canada encourages informed, collaborative decision-making between patients and their oncology teams. #progressCONNECT #breastcancerresearch

Millennium is an integrated healthcare system that offers all cancer treatment methods, and radiotherapy is one of the most prominent. Intense energy beams are used to destroy cancer cells using X-rays or proton radiation. As approximately 50% of patients receive radiotherapy during some stage of cancer treatment, radiotherapy may be used as a treatment alone or in conjunction with other treatments, such as chemotherapy or surgery. External radiation therapy is highly safe as the beams are directed directly at the cancer site while protecting healthy tissue until the genetic material that controls cell growth and division is destroyed. According to the latest reports, radiotherapy has achieved success rates ranging from 80% to 90% with some types of cancer, and treatment effects appear over time, not immediately. Some side effects of radiation therapy may appear, but they can be controlled with the doctor’s instructions We welcome all your inquiries by contacting us at: +201016372207 Or via WhatsApp: https://wa.link/wfgmz2 We welcome your visit to our branch addresses: ->Mohandiseen: 54, first floor, Abdel Moneim Riad Street https://bit.ly/48WCsni -> Sheikh Zayed: Al Nada Clinics Building, Sodic West #millennium_health_care #radiotherapy #oncology #cancer #cancersupport #earlydetectionsaveslives #MyHealth #endcancer #cancersurvivor #cancercommunity #clinics #CancerAwareness

Why is cancer staging important? 🤔 The overall stage of cancer gives information on the location, extent, and severity of the disease. Cancer staging helps oncologists determine the best treatment option, such as surgery, radiotherapy, chemotherapy, immunotherapy, or hormone therapy. Different stages of cancer influence survival statistics and help determine prognosis. Cancer staging is also useful in informing how likely a treatment is to be successful and sets expectations for the road ahead. With many advanced cancers, the treatment aim is disease control, whereas with most early-stage cancers, the treatment aim is curative. By comparing similar cases in patients with the same stage of disease, it allows doctors to predict possible challenges and help the patient prepare. Click below to learn more about the different stages of cancer and staging systems, how cancer stages are determined, and their role in determining treatment plans. Link: https://lnkd.in/eySrDSe9 #cancerawareness #morelife #earlydetection